# JD.com, Inc.: Form 20-F for the period ended Dec 31, 2024

- Company: [JD.com, Inc.](/companies/jd.md) (CIK 1549802)
- Form: 20-F
- Filed: 2025-04-17
- Accepted by EDGAR: Apr 17, 2025, 06:56 ET
- Period: 2024-12-31
- Accession: 0001193125-25-083473
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1549802/000119312525083473/d871796d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549802/000119312525083473/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $158.76bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $133.57bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $2.33bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | $5.31bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $397.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | $943.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | $6.12bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | $1.84 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | $1.90 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 3,076,061,616 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | $7.96bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $733.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months, 2024-01-01 to 2024-12-31 | $1.13bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2024-01-01 to 2024-12-31 | $3.55bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2024-12-31 | $14.84bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $52.98bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $95.66bn | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $41.03bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $52.74bn | us-gaap:Liabilities |
| Short-term borrowings | at 2024-12-31 | $1.04bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2024-12-31 | $32.79bn | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549802/000119312525083473/d871796d20f.htm

Filed Apr 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-083473. Last ingested by Listed: Nov 12, 2026, 17:47 ET. No prices; not investment advice.
